Treatment as Prevention¨

CANOC fact sheet: Learn about the largest nationwide study of people living with HIV on treatment

Uncategorized / By

This week, we are sharing a fact sheet on the Canadian Observational Cohort (CANOC): Canada’s largest multi-province study of people living with HIV on antiretroviral therapy. CANOC is an integrated network of all registered treatment information from eleven cohort databases across British Columbia, Ontario, Quebec, Saskatchewan and Newfoundland. This collaboration of national researchers and select databases establishes policy-relevant studies in HIV therapeutics, population and public health.

CANOC fact sheet: Learn about the largest nationwide study of people living with HIV on treatment Read More »

MOSH brings health care to people living on the streets, while Halifax faces HIV outbreak.

By

It’s a Thursday morning in March, and the red Toyota Sienna is ready to start on its route from the North End Community Health Centre on Gottingen Street through the streets of Halifax. To most, the van goes unnoticed. Besides the slightly raised ceiling, the only distinguishing feature on the van is a vanity plate

MOSH brings health care to people living on the streets, while Halifax faces HIV outbreak. Read More »

Scientists have found a way to completely stop the spread of HIV

By

The end of the era of AIDS can be a matter of time after a large-scale study of 1,000 males whose HIV infection was completely suppressed with antiretroviral drugs, didn’t infect their partners. “The success of the therapy means that if all HIV-positive people received treatment, further spread of the infection would not happen,” writes

Scientists have found a way to completely stop the spread of HIV Read More »

U=U vs. TasP

By

Undetectable equals Untransmittable/U=U vs. Treatment as Prevention (TasP). One has captured the imagination of people living with HIV (PLWH) around the world while the other seems to have disappeared. U=U was created by community to empower PLWH to have an undetectable viral load so they can’t transmit HIV. TasP was created by scientists to explain

U=U vs. TasP Read More »

Drugmaker Gilead Is Making HIV Prevention Meds More Accessible

By

Earlier this month, pharmaceutical company Gilead Sciences announced that it will donate enough HIV prevention drug Truvada to the Centers for Disease Control and Prevention (CDC) to benefit 200,000 people at risk for HIV. While news of the announcement was met positively, it also came ahead of some other negative headlines surrounding the drugmaker, coupled

Drugmaker Gilead Is Making HIV Prevention Meds More Accessible Read More »

Houston Health Department launches I am Life™ campaign to educate audiences about preventing HIV through PrEP, Treatment as Prevention (TasP) to end HIV transmission

By

A high number of HIV cases among the LGBTQ community’s African-American and Hispanic populations has become one of the top health crises in the Houston area and the southern United States. Specifically, the sub-groups at greater risk of acquiring HIV are African-American and Hispanic men who have sex with men (MSM) and transgender people of

Houston Health Department launches I am Life™ campaign to educate audiences about preventing HIV through PrEP, Treatment as Prevention (TasP) to end HIV transmission Read More »

Structure of T cell epitopes a decisive factor in natural HIV control, study finds

By

Researchers apply network theory to HIV protein structure, uncovering a vital link between connectivity and protective immune response. In 2017, nearly 37 million people were living with HIV worldwide, according to the Joint United Nations Program on HIV/AIDS (UNAIDS). Current treatments for the virus, which becomes AIDS in its most advanced stage, involve a combination

Structure of T cell epitopes a decisive factor in natural HIV control, study finds Read More »

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search